Q4 2024 13F Holders as of 31 Dec 2024
-
Type / Class
-
Equity / Common Stock, $0.001 par value
-
Shares outstanding
-
99,963,154
-
Total 13F shares
-
94,376,685
-
Share change
-
+1,413,870
-
Total reported value
-
$12,879,887,685
-
Put/Call ratio
-
94%
-
Price per share
-
$136.50
-
Number of holders
-
596
-
Value change
-
+$230,192,847
-
Number of buys
-
292
-
Number of sells
-
281
Institutional Holders of NEUROCRINE BIOSCIENCES INC - Common Stock, $0.001 par value (NBIX) as of Q4 2024
As of 31 Dec 2024,
NEUROCRINE BIOSCIENCES INC - Common Stock, $0.001 par value (NBIX) was held by
596 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
94,376,685 shares.
The largest 10 holders included
BlackRock, Inc., VANGUARD GROUP INC, STATE STREET CORP, Dodge & Cox, CITADEL ADVISORS LLC, RENAISSANCE TECHNOLOGIES LLC, AQR CAPITAL MANAGEMENT LLC, GEODE CAPITAL MANAGEMENT, LLC, Bellevue Group AG, and MORGAN STANLEY.
This page lists
599
institutional shareholders reporting positions in this security
for the Q4 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.